Her initial research will focus on how hearing is affected by damage from ototoxic drugs such as gentamicin. She will use single-unit auditory nerve recordings, combined with histological and physiological techniques, to investigate how auditory function is disrupted at both the cellular and neural levels. We’re excited to welcome Arezou to the team and look forward to the impactful contributions she will make to our research!